EU Proposes Unilateral Solution To Northern Ireland Medicines Supply Problems
UK Plans Special Contingency Measure
Executive Summary
The latest proposals for solving regulatory and trade issues caused by Brexit and the Northern Ireland Protocol have been welcomed by EU and UK pharmaceutical industry bodies.
You may also be interested in...
EU’s Northern Ireland Drug Supply Solution Imminent
The European Commission’s legislative proposal will close the gaps in medicines regulation caused by Brexit and the Northern Ireland Protocol.
EU’s Northern Ireland Drug Supply Solution Imminent
The European Commission’s legislative proposal will close the gaps in medicines regulation caused by Brexit and the Northern Ireland Protocol.
UK Regulator ‘Optimistic’ About EU Proposals For Northern Ireland Drug Supply
Among the many problems thrown up by Brexit is how to deal with situations where an innovative product that falls within the scope of the EU centralized procedure is filed in Great Britain but not in the EU, potentially denying access to the medicine in Northern Ireland. A recent webinar saw officials from the UK regulator explain the new rules on medicines supply between GB and NI.